Trubion Pharmaceuticals Inc (TRBN1)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
2401 14TH AVENUE SEATTLE, WA 98121

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Trubion Pharmaceuticals Inc. a biopharmaceutical company engages in the development of protein therapeutic product candidates for the treatment of autoimmune diseases and cancer.

View SEC Filings from TRBN1 instead.

View recent insider trading info

Funds Holding TRBN1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TRBN1 BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ABBOTT LABORATORIES

  • 10% Owner
No longer subject to file 2010-10-28 0

ARCH VENTURE FUND V LP

ARCH V ENTREPRENEURS FUND LP

HEALTHCARE FOCUS FUND LP

ARCH VENTURE PARTNERS V LP

ARCH VENTURE PARTNERS V LLC

CRANDELL KEITH

BYBEE CLINTON

LAZARUS STEVEN

NELSEN ROBERT

  • 10% Owner
No longer subject to file 2010-10-28 0

FHM III, LLC

FRAZIER HEALTHCARE III, LP

FRAZIER AFFILIATES III, LP

FHM IV LLC

FRAZIER HEALTHCARE IV LP

FRAZIER AFFILIATES IV LP

  • 10% Owner
0 2010-10-28 0

SCHNELL DAVID

  • Director
No longer subject to file 2010-10-28 0

STROMATT SCOTT SVP AND CHIEF MEDICAL OFFICER

  • Officer
No longer subject to file 2010-10-28 0

GILLIS STEVEN EX. CHAIR. & PRESIDENT

  • Officer
  • Director
  • 10% OWNER INDIRECT
No longer subject to file 2010-10-28 0

MCKEREGHAN KATHLEEN SVP AND GENERAL COUNSEL

  • Officer
No longer subject to file 2010-10-28 0

BURRIS MICHELLE SENIOR V.P. AND C.O.O.

  • Officer
No longer subject to file 2010-10-28 0

SAKS SAMUEL R

  • Director
No longer subject to file 2010-10-28 0

BRETTMAN LEE R

  • Director
No longer subject to file 2010-10-28 0

HERON PATRICK J

  • Director
  • 10% OWNER INDIRECT
No longer subject to file 2010-10-28 0

HOVE ANDERS D

  • Director
No longer subject to file 2010-10-28 0

MANN DAVID A

  • Director
No longer subject to file 2010-10-28 0

MOHLER KENDALL SVP & CHIEF SCIENTIFIC OFFICER

  • Officer
No longer subject to file 2010-10-28 0

BENCICH JOHN V.P. AND CFO

  • Officer
No longer subject to file 2010-10-28 0

ABBOTT BIOTHERAPEUTICS CORP

  • 10% Owner
No longer subject to file 2010-09-27 0

THOMPSON PETER A PRESIDENT AND CEO

  • Officer
  • Director
386,419 2009-08-27 0

FHM III, LLC

FRAZIER HEALTHCARE III, LP

FRAZIER AFFILIATES III, LP

FHM IV LP

FRAZIER HEALTHCARE IV LP

FRAZIER AFFILIATES IV LP

  • 10% Owner
2,195,556 2006-10-23 0

OXFORD BIOSCIENCE PARTNERS IV LP

MRNA FUND II LP

BARNES JEFFREY T

CARTHY MARK

FLEMING JONATHAN

LYTTON MICHAEL

WALTON ALAN G

OBP MANAGEMENT IV LP

  • 10% Owner
2,197,300 2006-10-23 0

VENROCK MANAGEMENT IV, LLC

  • 10% Owner
1,512,111 2006-10-23 0

VENROCK PARTNERS, L.P.

  • 10% Owner
308,367 2006-10-23 0

VENROCK PARTNERS MANAGEMENT, LLC

  • 10% Owner
308,367 2006-10-23 0

VEF MANAGEMENT IV, LLC

  • 10% Owner
37,154 2006-10-23 0

VENROCK ASSOCIATES IV, L.P.

  • 10% Owner
1,512,111 2006-10-23 0

VENROCK ENTREPRENEURS FUND IV, L.P.

  • 10% Owner
37,154 2006-10-23 0

ARCH VENTURE FUND V LP

ARCH VENTURE PARTNERS V LP

ARCH VENTURE PARTNERS V LLC

CRANDELL KEITH

NELSEN ROBERT

BYBEE CLINTON

LAZARUS STEVEN

  • 10% Owner
68,402 2006-10-17 0

PROSPECT VENTURE PARTNERS II LP

PROSPECT ASSOCIATES II L P

PROSPECT MANAGEMENT CO II LLC

TANANBAUM JAMES B

BARKAS ALEXANDER E

HIRSCH RUSSELL C

  • 10% Owner
0 2006-10-17 0

LEDBETTER JEFFREY A

  • 10% Owner
366,768 2006-10-17 0

HAYDEN-LEDBETTER MARTHA

  • 10% Owner
155,479 2006-10-17 0

CLARK EDWARD A

  • 10% Owner
203,317 2006-10-17 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments